Literature DB >> 30753112

Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.

Melanie Cree-Green1,2, Anne-Marie Carreau1, Haseeb Rahat1, Yesenia Garcia-Reyes1, Bryan C Bergman3, Laura Pyle4,5, Kristen J Nadeau1,2.   

Abstract

Polycystic ovarian syndrome (PCOS) is associated with insulin resistance (IR) and altered muscle mitochondrial oxidative phosphorylation. IR in adults with obesity and diabetes is associated with changes in amino acid, free fatty acid (FFA), and mitochondrial acylcarnitine (AC) metabolism. We sought to determine whether these metabolites are associated with IR and/or androgens in youth-onset PCOS. We enrolled obese girls with PCOS [ n = 15, 14.5 yr (SD 1.6), %BMI 98.5 (SD 1.0)] and without PCOS [ n = 6, 13.2 yr (SD 1.2), %BMI 98.0 (SD 1.1)]. Insulin sensitivity was assessed by hyperinsulinemic euglycemic clamp. Untargeted metabolomics of plasma was performed while fasting and during hyperinsulinemia. Fasting arginine, glutamine, histidine, lysine, phenylalanine, and tyrosine were higher ( P < 0.04 for all but P < 0.001 for valine), as were glutamine and histidine during hyperinsulinemia ( P < 0.03). Higher valine during hyperinsulinemia was associated with IR ( r = 0.59, P = 0.006). Surprisingly, end-clamp AC C4 was lower in PCOS, and lower C4 was associated with IR ( r = -0.44, P = 0.04). End-clamp FFAs of C14:0, C16:1, and C18:1 were higher in PCOS girls, and C16:1 and C18:1 strongly associated with IR ( r = 0.73 and 0.53, P < 0.01). Free androgen index related negatively to short-, medium-, and long-chain AC ( r = -0.41 to -0.71, P < 0.01) but not FFA or amino acids. Obese girls with PCOS have a distinct metabolic signature during fasting and hyperinsulinemia. As in diabetes, IR related to valine and FFAs, with an unexpected relationship with AC C4, suggesting unique metabolism in obese girls with PCOS.

Entities:  

Keywords:  amino acids; free fatty acids; insulin resistance; metabolomics; polycystic ovarian syndrome

Mesh:

Substances:

Year:  2019        PMID: 30753112      PMCID: PMC6580169          DOI: 10.1152/ajpendo.00532.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  56 in total

1.  Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial.

Authors:  R C Jensen; L L Christensen; J Nielsen; H D Schrøder; T Kvorning; K Gejl; K Højlund; D Glintborg; M Andersen
Journal:  Andrology       Date:  2018-04-15       Impact factor: 3.842

2.  Validation of an instrument for measurement of physical activity in youth.

Authors:  A T Weston; R Petosa; R R Pate
Journal:  Med Sci Sports Exerc       Date:  1997-01       Impact factor: 5.411

3.  Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment.

Authors:  Natalya Filipchuk Vigerust; Pavol Bohov; Bodil Bjørndal; Reinhard Seifert; Ottar Nygård; Asbjørn Svardal; Dorte Glintborg; Rolf Kristian Berge; Michael Gaster
Journal:  Fertil Steril       Date:  2012-09-19       Impact factor: 7.329

4.  Metabolite profiles and the risk of developing diabetes.

Authors:  Thomas J Wang; Martin G Larson; Ramachandran S Vasan; Susan Cheng; Eugene P Rhee; Elizabeth McCabe; Gregory D Lewis; Caroline S Fox; Paul F Jacques; Céline Fernandez; Christopher J O'Donnell; Stephen A Carr; Vamsi K Mootha; Jose C Florez; Amanda Souza; Olle Melander; Clary B Clish; Robert E Gerszten
Journal:  Nat Med       Date:  2011-03-20       Impact factor: 53.440

Review 5.  Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.

Authors:  A Baranova; T P Tran; A Birerdinc; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-01-20       Impact factor: 8.171

6.  Method for controlled mitochondrial perturbation during phosphorus MRS in children.

Authors:  Melanie Cree-Green; Bradley R Newcomer; Mark Brown; Amber Hull; Amy D West; Debra Singel; Jane E B Reusch; Kim McFann; Judith G Regensteiner; Kristen J Nadeau
Journal:  Med Sci Sports Exerc       Date:  2014-10       Impact factor: 5.411

7.  Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance.

Authors:  P Sjögren; J Sierra-Johnson; K Gertow; M Rosell; B Vessby; U de Faire; A Hamsten; M-L Hellenius; R M Fisher
Journal:  Diabetologia       Date:  2007-11-20       Impact factor: 10.122

Review 8.  Interplay between lipids and branched-chain amino acids in development of insulin resistance.

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

9.  Diversity in levels of intracellular total creatine and triglycerides in human skeletal muscles observed by (1)H-MRS.

Authors:  J Rico-Sanz; E L Thomas; G Jenkinson; S Mierisová; R Iles; J D Bell
Journal:  J Appl Physiol (1985)       Date:  1999-12

10.  Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.

Authors:  Kim M Huffman; Svati H Shah; Robert D Stevens; James R Bain; Michael Muehlbauer; Cris A Slentz; Charles J Tanner; Maragatha Kuchibhatla; Joseph A Houmard; Christopher B Newgard; William E Kraus
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

View more
  5 in total

1.  Editoral commentary: Understanding cardiovascular disease risk in women with polycystic ovary syndrome.

Authors:  Melanie Cree-Green
Journal:  Trends Cardiovasc Med       Date:  2019-09-24       Impact factor: 6.677

Review 2.  Metabolomics in Central Sensitivity Syndromes.

Authors:  Joseph S Miller; Luis Rodriguez-Saona; Kevin V Hackshaw
Journal:  Metabolites       Date:  2020-04-24

3.  Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Mohd Falihin Mohd Shukri; Mohd Noor Norhayati; Salziyan Badrin; Azidah Abdul Kadir
Journal:  PeerJ       Date:  2022-09-16       Impact factor: 3.061

4.  Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.

Authors:  Beza Tayachew; Heidi Vanden Brink; Yesenia Garcia-Reyes; Haseeb Rahat; Angelo D'Alessandro; Daniel N Frank; Charles E Robertson; Lori Silveira; Megan Kelsey; Laura Pyle; Melanie Cree-Green
Journal:  Front Physiol       Date:  2022-06-21       Impact factor: 4.755

5.  How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.

Authors:  Xiaoxuan Zhao; Xiaoling Feng; Xinjie Zhao; Yuepeng Jiang; Xianna Li; Jingyun Niu; Xiaoyu Meng; Jing Wu; Guowang Xu; Lihui Hou; Ying Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.